INFINITT Healthcare

At a glance

INFINITT Healthcare filed 65 disclosures in the last 12 months, including 5 5% holder and 2 insider. The most recent key filing was on Sep 21.

Revenue for 2025 was ₩102B, up 6.9% on 2024. Operating margin was 13.9% against 8.1% a year earlier. Debt was 28% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩57.6B and operating profit of ₩14.4B.

The 2025 annual report lists 246 employees with an average tenure of 10.7 years and average pay of ₩56.2M, #1159 of 1,829 listed companies by average pay. Its 8 directors and auditors were paid ₩238M each on average. It paid ₩200 per common share in cash dividends. (주)솔본 and related parties held 50.50% at year end.

From the 2025 annual report

Staff: 246 (194 men, 52 women), of whom 1 on fixed-term contracts. Total pay for the year: ₩13.8B. Directors and auditors: 8, paid ₩1.9B in total.

Dividends (common shares)

Largest shareholder

(주)솔본 holds 48.66%; with 4 related parties the group holds 50.50% of common shares at year end (from 47.11% at the start of the year).

Individuals paid ₩500M or more

Auditor: 우리회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary